معرفی
Dr. Brian Robertson is an Associate Professor in Systems Microbiology at the Department of Infectious Disease, Faculty of Medicine, Imperial College London. He is affiliated with the Centre for Bacterial Resistance Biology, Section of Molecular Microbiology, Vaccine Research Network End-TB Tuberculosis, and Institute of Infection. His research focuses on Mycobacterium tuberculosis pathogenesis, vaccine development, and antimicrobial therapies, addressing the global burden of tuberculosis. Robertson’s work emphasizes improving diagnostics, drugs, and vaccines to meet the WHO End-TB strategy goals of reducing TB incidence and mortality by 2035.
His research interests span microbiology, medical microbiology, immunology, biochemistry, pharmacology, and clinical sciences. He employs innovative models like Galleria mellonella and precision-cut lung slices to study host-pathogen interactions, drug efficacy, and vaccine candidates. Robertson’s team also explores molecular mechanisms of mycobacterial virulence, including lipid-mediated host protein inhibition and extracellular matrix degradation.
Recent publications highlight advancements in BCG skin challenge models, antimicrobial peptide design, and the role of acidic microenvironments in TB progression. His work bridges fundamental research and translational medicine, aiming to combat drug resistance and optimize treatment strategies. Grants and collaborations likely support his research, though specific details are not detailed here.
Robertson’s affiliations indicate strong institutional support for tackling tuberculosis through interdisciplinary approaches. His research aligns with global health priorities, emphasizing equitable access to effective treatments and preventive measures against TB.
